Aerie Pharmaceuticals, Inc. Increase (Decrease) in Contract with Customer, Liability
Aerie Pharmaceuticals, Inc. reported Increase (Decrease) in Contract with Customer, Liability of $6.57 million for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-04.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInContractWithCustomerLiability · last filed 2022-11-04
- Aerie Pharmaceuticals, Inc. increase (decrease) in contract with customer, liability for the quarter ending 2022-09-30 was $443.00K, a 49.14% decline year-over-year.
- Aerie Pharmaceuticals, Inc. increase (decrease) in contract with customer, liability for the quarter ending 2022-06-30 was $438.00K, a 64.19% decline year-over-year.
- Aerie Pharmaceuticals, Inc. increase (decrease) in contract with customer, liability for the quarter ending 2022-03-31 was $5.68M, a 661.04% increase year-over-year.
- Aerie Pharmaceuticals, Inc. increase (decrease) in contract with customer, liability for the quarter ending 2021-12-31 was $10.62M, a 79.13% decline year-over-year.
- Aerie Pharmaceuticals, Inc. increase (decrease) in contract with customer, liability for fiscal 2021 was $13.46M, a 73.54% decline from fiscal 2020.
- Aerie Pharmaceuticals, Inc. increase (decrease) in contract with customer, liability for fiscal 2020 was $50.86M.
- Aerie Pharmaceuticals, Inc. increase (decrease) in contract with customer, liability for fiscal 2019 was $0.00.
- Aerie Pharmaceuticals, Inc. increase (decrease) in contract with customer, liability for fiscal 2018 was $0.00.
| Period end | Increase (Decrease) in Contract with Customer, Liability 3 month | Increase (Decrease) in Contract with Customer, Liability 6 month | Increase (Decrease) in Contract with Customer, Liability 9 month | Increase (Decrease) in Contract with Customer, Liability 12 month |
|---|---|---|---|---|
| 2022-09-30 | $443.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | $881.00K derived: sum of 2 quarters · filed 2022-11-04 | $6.57M 10-Q · filed 2022-11-04 | $17.18M derived: sum of 4 quarters · filed 2022-11-04 |
| 2022-06-30 | $438.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | $6.12M 10-Q · filed 2022-08-05 | $16.74M derived: sum of 3 quarters · filed 2022-08-05 | $17.61M derived: sum of 4 quarters · filed 2022-11-04 |
| 2022-03-31 | $5.68M 10-Q · filed 2022-05-06 | $16.30M derived: sum of 2 quarters · filed 2022-05-06 | $17.17M derived: sum of 3 quarters · filed 2022-11-04 | $18.39M derived: sum of 4 quarters · filed 2022-11-04 |
| 2021-12-31 | $10.62M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $11.49M derived: sum of 2 quarters · filed 2022-11-04 | $12.71M derived: sum of 3 quarters · filed 2022-11-04 | $13.46M 10-K · filed 2022-02-25 |
| 2021-09-30 | $871.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | $2.09M derived: sum of 2 quarters · filed 2022-11-04 | $2.84M 10-Q · filed 2022-11-04 | $53.70M derived: sum of 4 quarters · filed 2022-11-04 |
| 2021-06-30 | $1.22M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | $1.97M 10-Q · filed 2022-08-05 | $52.83M derived: sum of 3 quarters · filed 2022-08-05 | $52.83M derived: sum of 4 quarters · filed 2022-08-05 |
| 2021-03-31 | $747.00K 10-Q · filed 2022-05-06 | $51.60M derived: sum of 2 quarters · filed 2022-05-06 | $51.60M derived: sum of 3 quarters · filed 2022-05-06 | $51.60M derived: sum of 4 quarters · filed 2022-05-06 |
| 2020-12-31 | $50.86M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $50.86M derived: sum of 2 quarters · filed 2022-02-25 | $50.86M derived: sum of 3 quarters · filed 2022-02-25 | $50.86M 10-K · filed 2022-02-25 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05 | $0.00 derived: sum of 2 quarters · filed 2021-11-05 | $0.00 10-Q · filed 2021-11-05 | |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $0.00 10-Q · filed 2021-08-05 | ||
| 2020-03-31 | $0.00 10-Q · filed 2021-05-06 | |||
| 2019-12-31 | $0.00 10-K · filed 2022-02-25 | |||
| 2018-12-31 | $0.00 10-K · filed 2021-02-26 |